Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Andrisael G Lacoste"'
Publikováno v:
Drugs in Context, Vol 7, Pp 1-11 (2018)
Heart failure (HF) is one of the leading causes of hospital readmissions and health care expenditures. With a vast degree of advancements in the clinical approach and diagnosis, its management protocol is limited in terms of enhancing quality of
Externí odkaz:
https://doaj.org/article/2086a30e03b149cd8e0e46ede5309bfd
Publikováno v:
Therapeutic Advances in Cardiovascular Disease
Therapeutic Advances in Cardiovascular Disease, Vol 14 (2020)
Therapeutic Advances in Cardiovascular Disease, Vol 14 (2020)
Introduction: Thyroid hormone (TH) has an essential role on the functional capability of cardiac muscle with its gene modulation and induction of vasodilatory effects. There is considerable evidence to suggest the role of TH in patients with acute co
Autor:
Andrisael G. Lacoste, Timothy J. Vittorio, Pranav Ravi, Neil Shah, Muhammad Saad, Umut Gomceli
Publikováno v:
Drugs in Context
Drugs in Context, Vol 7, Pp 1-11 (2018)
Drugs in Context, Vol 7, Pp 1-11 (2018)
Heart failure (HF) is one of the leading causes of hospital readmissions and health care expenditures. With a vast degree of advancements in the clinical approach and diagnosis, its management protocol is limited in terms of enhancing quality of life
Publikováno v:
Journal of the American College of Cardiology. 77:773
Autor:
Timothy J. Vittorio, Jonathan N. Bella, Manoj Bhandari, Nolberto Hernandez, Andrisael G. Lacoste, Lava Timsina, Bushra Zaidi, Muhammad Saad, Swathi Roy
Publikováno v:
Journal of Cardiac Failure. 25:S12
Background SGLT-2 inhibition reduces preload as well as afterload, arterial stiffness and systemic blood pressure thereby improving subendocardial blood flow in patients with heart failure (HF). These beneficial cardiovascular (CV) effects likely low